Indaptus Therapeutics Stock (NASDAQ: INDP) stock price, news, charts, stock research, profile.
Open | $2.310 |
Close | $2.180 |
Volume / Avg. | 29.204K / 85.335K |
Day Range | 2.150 - 2.323 |
52 Wk Range | 1.560 - 4.080 |
Market Cap | $23.482M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 1.67% |
Days to Cover | 1.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Indaptus Therapeutics (NASDAQ: INDP) through any online brokerage.
Other companies in Indaptus Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Vaxxinity (NASDAQ:VAXX) and Dominari Holdings (NASDAQ:DOMH).
The latest price target for Indaptus Therapeutics (NASDAQ: INDP) was reported by HC Wainwright & Co. on Monday, April 15, 2024. The analyst firm set a price target for 12.00 expecting INDP to rise to within 12 months (a possible 336.36% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Indaptus Therapeutics (NASDAQ: INDP) is $2.75 last updated April 17, 2024 at 7:37 AM EDT.
There are no upcoming dividends for Indaptus Therapeutics.
Indaptus Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Indaptus Therapeutics.
Indaptus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.